Operating income decreased 38.5%
Operating income changed -38.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -38.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -249 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +368 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +23.5% from the comparable as-filed period.
Shares outstanding changed -3.7% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Gross margin changed -76 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +686 basis points from the comparable as-filed period.
Revenue changed -3.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -16.8% from the comparable as-filed period.
Working capital changed +12.9% from the comparable as-filed period.
Current ratio changed +21.4% from the comparable as-filed period.
Operating cash flow changed -5.0% from the comparable as-filed period.
Inventory changed +5.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed -22.5% from the comparable as-filed period.
Free-cash-flow proxy changed -2.2% from the comparable as-filed period.
Gross profit changed -7.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -20 basis points from the comparable as-filed period.
SBC / revenue changed -2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -7.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -2.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed -2.2% from the comparable as-filed period.
Current assets changed +1.0% from the comparable as-filed period.
Operating cash-flow margin changed -12 basis points from the comparable as-filed period.
Free-cash-flow margin changed +8 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -50.4% from the comparable as-filed period.
Operating cash flow changed -44.8% from the comparable as-filed period.
Cash & equivalents changed +72.2% from the comparable as-filed period.
Operating income changed -28.8% from the comparable as-filed period.
Operating margin changed -125 basis points from the comparable as-filed period.
Working capital / assets changed +482 basis points from the comparable as-filed period.
Working capital changed +14.9% from the comparable as-filed period.
Free-cash-flow margin changed -653 basis points from the comparable as-filed period.
Capital expenditure changed +49.8% from the comparable as-filed period.
Operating cash-flow margin changed -607 basis points from the comparable as-filed period.
Revenue changed -4.5% from the comparable as-filed period.
Gross margin changed +43 basis points from the comparable as-filed period.
Current assets changed +5.9% from the comparable as-filed period.
Current liabilities changed -6.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +87 basis points from the comparable as-filed period.
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Current ratio changed +12.7% from the comparable as-filed period.
Total assets changed +3.1% from the comparable as-filed period.
Capex / revenue changed +46 basis points from the comparable as-filed period.
Inventory changed -2.9% from the comparable as-filed period.
Cost of revenue changed -5.0% from the comparable as-filed period.
SBC / revenue changed +6 basis points from the comparable as-filed period.
Stock-based compensation changed +6.7% from the comparable as-filed period.
Gross profit changed -1.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.